Korean J Dermatol.  2002 Jun;40(6):616-619.

Therapeutic Effect of Microsclerotherapy in the Treatment of Facial Telangiectasia

Affiliations
  • 1Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea. jbmlee@chonnam.ac.kr

Abstract

BACKGROUND: The treatment of facial telangiectasia include microsclerotherapy, laser, and electrosurgery. It is important that the treatment for telangiectasia be relatively risk-free, especially avoiding unsightly scarring.
OBJECTIVE
We evaluated the effectiveness, complications, and recurrence rate of patients with facial telangiectasia treated with microsclerotherapy using osmotic sclerosing agent. In addition, we also evaluated the associated factors, the sites of predilection, and types of facial telangiectasia.
PATIENTS AND METHODS
Fifteen patients with facial telangiectasia were treated with microsclerotherapy using osmotic sclerosant(Sclerodex(R)). The procedure was performed at 4 week intervals and on average 2 times. The effectiveness was evaluated by the comparison of photographs monthly during mean 6 months follow-up period.
RESULTS
Mean improvement rate was 70% and partial recurrence was observed in 3 cases(20%). Transient bruising(33%), transient pigmentation(7%) and telangiectatic matting(7%) were observed as complications.
CONCLUSION
Sclerotherapy with osmotic sclerosant(Sclerodex(R)) is safe and moderately effective; because it usually has more than a good response and minimal complications.

Keyword

Sclerotherapy; Facial telangiectasia; Sclerodex(R)

MeSH Terms

Cicatrix
Electrosurgery
Follow-Up Studies
Humans
Recurrence
Sclerotherapy
Telangiectasis*
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr